AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2014
May 16, 2014
34519_dirs_2014-05-16_df30c6f0-173f-4129-9b87-c89561e52e16.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2014-05-15
Reporting Person: Tomsche David Scott (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-15 | Common Stock, par value $0.10 per share | P | 1000 | $3.51 | Acquired | 53668 | Direct |
| 2014-05-15 | Common Stock, par value $0.10 per share | P | 1000 | $3.63 | Acquired | 54668 | Direct |
| 2014-05-15 | Common Stock, par value $0.10 per share | P | 1000 | $3.5 | Acquired | 55668 | Direct |
| 2014-05-15 | Common Stock, par value $0.10 per share | P | 1000 | $3.71 | Acquired | 56668 | Direct |
Footnotes
F1: (1) This figure includes 2,322 shares of common stock held by immediate family members of Dr. Tomsche.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23